Adjunct devices for managing challenging cases in cataract surgery

Capsular staining and ophthalmic viscosurgical devices

James M. Goldman, Carol Karp

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Cataract surgeons should employ all reasonable technology to facilitate safe and consistent outcomes. Knowledge of adjunct devices to enhance visualization of the capsular bag and appropriate use of ophthalmic viscosurgical devices allow for enhanced protection of intraocular structures and reduced rates of complication. RECENT FINDINGS: Trypan blue is US Food and Drug Administration-approved for facilitating visualization of the anterior capsule. Animal data demonstrate Brilliant Blue G to be an effective capsular stain with a superior safety profile. Healon5 is a safe viscosurgical device that is particularly useful in children, poorly dilating pupils, intraoperative floppy-iris syndrome, and intumescent cataracts. The viscoadaptivity of Healon5 enables its utility throughout the procedure of cataract extraction. The recent literature on capsular dyes and advances in ophthalmic viscosurgical technology is reviewed. SUMMARY: Inadequate capsular visualization and poor tissue stabilization/protection increase the chance of discontinuous capsulorhexis, retained nuclear material, vitreous loss and corneal decompensation. Utilization of adjunctive tools in the setting of challenging cataract cases can significantly limit adverse intraoperative outcomes and result in reproducible surgical success.

Original languageEnglish
Pages (from-to)52-57
Number of pages6
JournalCurrent Opinion in Ophthalmology
Volume18
Issue number1
DOIs
StatePublished - Feb 1 2007

Fingerprint

Cataract
Staining and Labeling
Equipment and Supplies
Coloring Agents
Capsulorhexis
Technology
Cataract Extraction
Trypan Blue
Iris
United States Food and Drug Administration
Pupil
Capsules
Safety
coomassie Brilliant Blue
Surgeons

Keywords

  • Anterior capsule
  • Capsulorhexis
  • Healon5
  • Ophthalmic viscosurgical device
  • Trypan blue
  • Viscoelastic

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Adjunct devices for managing challenging cases in cataract surgery : Capsular staining and ophthalmic viscosurgical devices. / Goldman, James M.; Karp, Carol.

In: Current Opinion in Ophthalmology, Vol. 18, No. 1, 01.02.2007, p. 52-57.

Research output: Contribution to journalArticle

@article{094c17db003b46608fd60f0b5292fd7b,
title = "Adjunct devices for managing challenging cases in cataract surgery: Capsular staining and ophthalmic viscosurgical devices",
abstract = "PURPOSE OF REVIEW: Cataract surgeons should employ all reasonable technology to facilitate safe and consistent outcomes. Knowledge of adjunct devices to enhance visualization of the capsular bag and appropriate use of ophthalmic viscosurgical devices allow for enhanced protection of intraocular structures and reduced rates of complication. RECENT FINDINGS: Trypan blue is US Food and Drug Administration-approved for facilitating visualization of the anterior capsule. Animal data demonstrate Brilliant Blue G to be an effective capsular stain with a superior safety profile. Healon5 is a safe viscosurgical device that is particularly useful in children, poorly dilating pupils, intraoperative floppy-iris syndrome, and intumescent cataracts. The viscoadaptivity of Healon5 enables its utility throughout the procedure of cataract extraction. The recent literature on capsular dyes and advances in ophthalmic viscosurgical technology is reviewed. SUMMARY: Inadequate capsular visualization and poor tissue stabilization/protection increase the chance of discontinuous capsulorhexis, retained nuclear material, vitreous loss and corneal decompensation. Utilization of adjunctive tools in the setting of challenging cataract cases can significantly limit adverse intraoperative outcomes and result in reproducible surgical success.",
keywords = "Anterior capsule, Capsulorhexis, Healon5, Ophthalmic viscosurgical device, Trypan blue, Viscoelastic",
author = "Goldman, {James M.} and Carol Karp",
year = "2007",
month = "2",
day = "1",
doi = "10.1097/ICU.0b013e3280121b24",
language = "English",
volume = "18",
pages = "52--57",
journal = "Current Opinion in Ophthalmology",
issn = "1040-8738",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Adjunct devices for managing challenging cases in cataract surgery

T2 - Capsular staining and ophthalmic viscosurgical devices

AU - Goldman, James M.

AU - Karp, Carol

PY - 2007/2/1

Y1 - 2007/2/1

N2 - PURPOSE OF REVIEW: Cataract surgeons should employ all reasonable technology to facilitate safe and consistent outcomes. Knowledge of adjunct devices to enhance visualization of the capsular bag and appropriate use of ophthalmic viscosurgical devices allow for enhanced protection of intraocular structures and reduced rates of complication. RECENT FINDINGS: Trypan blue is US Food and Drug Administration-approved for facilitating visualization of the anterior capsule. Animal data demonstrate Brilliant Blue G to be an effective capsular stain with a superior safety profile. Healon5 is a safe viscosurgical device that is particularly useful in children, poorly dilating pupils, intraoperative floppy-iris syndrome, and intumescent cataracts. The viscoadaptivity of Healon5 enables its utility throughout the procedure of cataract extraction. The recent literature on capsular dyes and advances in ophthalmic viscosurgical technology is reviewed. SUMMARY: Inadequate capsular visualization and poor tissue stabilization/protection increase the chance of discontinuous capsulorhexis, retained nuclear material, vitreous loss and corneal decompensation. Utilization of adjunctive tools in the setting of challenging cataract cases can significantly limit adverse intraoperative outcomes and result in reproducible surgical success.

AB - PURPOSE OF REVIEW: Cataract surgeons should employ all reasonable technology to facilitate safe and consistent outcomes. Knowledge of adjunct devices to enhance visualization of the capsular bag and appropriate use of ophthalmic viscosurgical devices allow for enhanced protection of intraocular structures and reduced rates of complication. RECENT FINDINGS: Trypan blue is US Food and Drug Administration-approved for facilitating visualization of the anterior capsule. Animal data demonstrate Brilliant Blue G to be an effective capsular stain with a superior safety profile. Healon5 is a safe viscosurgical device that is particularly useful in children, poorly dilating pupils, intraoperative floppy-iris syndrome, and intumescent cataracts. The viscoadaptivity of Healon5 enables its utility throughout the procedure of cataract extraction. The recent literature on capsular dyes and advances in ophthalmic viscosurgical technology is reviewed. SUMMARY: Inadequate capsular visualization and poor tissue stabilization/protection increase the chance of discontinuous capsulorhexis, retained nuclear material, vitreous loss and corneal decompensation. Utilization of adjunctive tools in the setting of challenging cataract cases can significantly limit adverse intraoperative outcomes and result in reproducible surgical success.

KW - Anterior capsule

KW - Capsulorhexis

KW - Healon5

KW - Ophthalmic viscosurgical device

KW - Trypan blue

KW - Viscoelastic

UR - http://www.scopus.com/inward/record.url?scp=33845654684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845654684&partnerID=8YFLogxK

U2 - 10.1097/ICU.0b013e3280121b24

DO - 10.1097/ICU.0b013e3280121b24

M3 - Article

VL - 18

SP - 52

EP - 57

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

SN - 1040-8738

IS - 1

ER -